Search Within

Alison Michele Schram

Formats
  1. Meeting Abstract (57)
  2. Journal Article (56)
  3. Editorial (3)
  4. Review (3)
  5. Miscellaneous (2)
  6. Research Letter (1)
Groups
  1. Department of Medicine (122)
  2. Early Drug Development Service (122)
  3. Gynecologic Medicine Service (122)
  4. Solid Tumor Oncology Division (122)
  5. GSK Faculty (52)
  6. Thoracic Oncology (50)

More Groups

People
  1. David Hyman (49)
  2. Alexander Drilon (46)
  3. Michael Berger (23)
  4. Barry Taylor (16)
  5. Marc Ladanyi (16)
  6. Helen Won (14)

More People

Years
  1. 2025 (4)
  2. 2024 (18)
  3. 2023 (9)
  4. 2022 (16)
  5. 2021 (17)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Annals of Oncology (13)
  3. Cancer Research (13)
  4. Cancer Discovery (8)
  5. Clinical Cancer Research (5)
  6. JCO Precision Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (33)
  2. American Association for Cancer Research (29)
  3. Oxford University Press (14)
  4. Nature Publishing Group (12)
  5. Elsevier Inc. (10)
  6. American Medical Association (3)

More Publishers

Results (122)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncologist use and perception of large panel next-generation tumor sequencing
    Journal Article

    Schram, A. M.; Reales, D.; Galle, J.; Cambria, R.; Durany, R.; Feldman, D.; Sherman, E.; Rosenberg, J.; D'Andrea, G.; Baxi, S.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion-positive solid tumors
    Journal Article

    Drilon, A.; Nagasubramanian, R.; Blake, J. F.; Ku, N.; Tuch, B. B.; Ebata, K.; Smith, S.; Lauriault, V.; Kolakowski, G. R.; Brandhuber, B. J.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Quantifying the benefits of genome-driven oncology
    Journal Article

    Schram, A. M.; Hyman, D. M.
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
    Journal Article

    Sabari, J. K.; Santini, F. C.; Schram, A. M.; Bergagnini, I.; Chen, R.; Mrad, C.; Lai, W. V.; Arbour, K. C.; Drilon, A.
    OncoTargets and Therapy (2017)

    Fulltext@MSK | Save
  • Precision oncology: Charting a path forward to broader deployment of genomic profiling
    Journal Article

    Schram, A. M.; Berger, M. F.; Hyman, D. M.
    PLos Medicine (2017)

    Fulltext@MSK | Save
  • Niraparib in recurrent ovarian cancer
    Journal Article

    Schram, A. M.; Aghajanian, C. A.; Hyman, D. M.
    New England Journal of Medicine (2017)

    Fulltext@MSK | Save
  • Genome-driven paradigm for the development of selective fibroblast growth factor receptor inhibitors
    Journal Article

    Schram, A. M.; Voss, M. H.; Hyman, D. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Picking the right patient for human epidermal growth factor receptor 3 - Targeted therapy in platinum-resistant ovarian cancer
    Journal Article

    Schram, A. M.; Iasonos, A.; Hyman, D. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genetic and functional investigation of germline JAK2 alleles that predispose to myeloproliferative neoplasms
    Meeting Abstract

    Schram, A. M.; Xu, X.; Kilpivaara, O.; Mukherjee, S.; Viny, A. D.; Guryanova, O.; Klein, R. J.; Levine, R. L.
    Blood (2011)

    Fulltext@MSK | Save